Policy Update-Wk of 5/11

posted on

In the Health Reform Update for the past week, a House committee advances a draft version of “21st Century Cures” legislation to expedite drug approvals, while exclusivity for biologic drugs becomes a sticking point in trade legislation blocked by the Senate.

Hawaii’s governor agrees to turn control over the state’s beleaguered Marketplace web portal to the federal government.    Marketplaces in Colorado and Connecticut approve increases in insurer assessments in order to remain self-sustaining, while California chooses instead to slash spending.   Consumer groups claim that the Texas House passed a “scarlet letter” bill by requiring insurance cards tell providers if a subscriber is enrolled in a Marketplace and receiving Affordable Care Act subsidies.

Washington becomes the fourth state this year to enact restrictions on the substitution of lower-cost biosimilars for brand-name biologic drugs.    

A new study shows that the number of Americans with at least $100,000 in annual drug costs nearly tripled in 2014.

You can find the full Health Reform Update here and if you’re interested in Advocacy, you can also join the PSI Patient Coalition.



Posted in: Government Relations | Tags: | Comments (0) | View Count: (2305)
Comment function is not open